InsiderDB
Sign inStart free trial

Rep. Daniel S. Goldman sold Ono Pharmaceutical Co. (OPHLY)

Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Jul 10, 2023

Transaction
Sold
Amount
$1K–$15K
Owner
Not stated
Traded
Jul 10, 2023
Disclosed
Aug 13, 2023
Days to disclose
34
Asset type
Stock
As filed
Ono Pharmaceutical Co Ltd Unsponsored ADR
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Goldman's tradesAll Congress trades in OPHLY

Other trades in this filing

All of Goldman's trades →

Company context for OPHLY

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. OPHLYLobbying report·Lobbying disclosures

    OPHLY: third_quarter 2026 lobbying report

    Monitor administrative and legislative action affecting FDA drug approvals

    Public: Oct 19, 2026, 8:38 AM EDTOriginal source ↗
  2. OPHLYLobbying report·Lobbying disclosures

    OPHLY: second_quarter 2026 lobbying report

    Monitor administrative and legislative action affecting FDA drug approvals

    Public: Jul 20, 2026, 9:30 AM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.